Press Releases

02 Mar '22
WALTHAM, Mass. , March 02, 2022 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a biopharmaceutical company focused on the development of T cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer, today announced that the Company will...
Additional Formats
Displaying 11 - 20 of 21